Literature DB >> 24151834

Clostridium difficile surveillance: harnessing new technologies to control transmission.

David W Eyre1, A Sarah Walker.   

Abstract

Clostridium difficile surveillance allows outbreaks of cases clustered in time and space to be identified and further transmission prevented. Traditionally, manual detection of groups of cases diagnosed in the same ward or hospital, often followed by retrospective reference laboratory genotyping, has been used to identify outbreaks. However, integrated healthcare databases offer the prospect of automated real-time outbreak detection based on statistically robust methods, and accounting for contacts between cases, including those distant to the ward of diagnosis. Complementary to this, rapid benchtop whole genome sequencing, and other highly discriminatory genotyping, has the potential to distinguish which cases are part of an outbreak with high precision and in clinically relevant timescales. These new technologies are likely to shape future surveillance.

Entities:  

Mesh:

Year:  2013        PMID: 24151834     DOI: 10.1586/14787210.2013.845987

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  10 in total

Review 1.  Progress in Biomedical Knowledge Discovery: A 25-year Retrospective.

Authors:  L Sacchi; J H Holmes
Journal:  Yearb Med Inform       Date:  2016-08-02

Review 2.  Diversity and Evolution in the Genome of Clostridium difficile.

Authors:  Daniel R Knight; Briony Elliott; Barbara J Chang; Timothy T Perkins; Thomas V Riley
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile.

Authors:  A Baktash; J Corver; C Harmanus; W K Smits; W Fawley; M H Wilcox; N Kumar; D W Eyre; A Indra; A Mellmann; E J Kuijper
Journal:  J Clin Microbiol       Date:  2021-12-15       Impact factor: 11.677

4.  Clostridioides difficile Whole-genome Sequencing Differentiates Relapse With the Same Strain From Reinfection With a New Strain.

Authors:  Janice Cho; Scott Cunningham; Meng Pu; Ryan J Lennon; Jennifer Dens Higano; Patricio Jeraldo; Priya Sampathkumar; Samantha Shannon; Purna C Kashyap; Robin Patel
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

5.  Genome Analysis of Clostridium difficile PCR Ribotype 014 Lineage in Australian Pigs and Humans Reveals a Diverse Genetic Repertoire and Signatures of Long-Range Interspecies Transmission.

Authors:  Daniel R Knight; Michele M Squire; Deirdre A Collins; Thomas V Riley
Journal:  Front Microbiol       Date:  2017-01-11       Impact factor: 5.640

6.  Evolutionary and Genomic Insights into Clostridioides difficile Sequence Type 11: a Diverse Zoonotic and Antimicrobial-Resistant Lineage of Global One Health Importance.

Authors:  Daniel R Knight; Brian Kullin; Grace O Androga; Frederic Barbut; Catherine Eckert; Stuart Johnson; Patrizia Spigaglia; Kazuhiro Tateda; Pei-Jane Tsai; Thomas V Riley
Journal:  mBio       Date:  2019-04-16       Impact factor: 7.867

7.  Why infectious diseases.

Authors:  John G Bartlett
Journal:  Clin Infect Dis       Date:  2014-09-15       Impact factor: 9.079

8.  Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017.

Authors:  Korakrit Imwattana; Papanin Putsathit; Deirdre A Collins; Teera Leepattarakit; Pattarachai Kiratisin; Thomas V Riley; Daniel R Knight
Journal:  Microb Genom       Date:  2022-03

9.  Comparative Whole Genome Sequence Analysis and Biological Features of Clostridioides difficile Sequence Type 2.

Authors:  Xingxing Xu; Qiao Bian; Yun Luo; Xiaojun Song; Shan Lin; Huan Chen; Qian Liang; Meixia Wang; Guangyong Ye; Bo Zhu; Liang Chen; Yi-Wei Tang; Xianjun Wang; Dazhi Jin
Journal:  Front Microbiol       Date:  2021-07-05       Impact factor: 5.640

Review 10.  Whole-genome sequencing to control antimicrobial resistance.

Authors:  Claudio U Köser; Matthew J Ellington; Sharon J Peacock
Journal:  Trends Genet       Date:  2014-08-03       Impact factor: 11.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.